Susan Hasty, Publisher
Table of Contents . . . August 30th, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Neurological Diseases and Disorders Weekly | Other Publications
Cognition - Defective Attention, Not Memory
Dementia - Cause of Death Examined in Community Study
Risk Factors - Familial Association Weaker than Previously Estimated
Therapy (Rivastigmine) - Clinical Trial Assesses Rivastigmine in AD Patients
Bacterial Infection (Pathology) - Scientists Report X-Rays Show How Bacteria Infect Cells
Diagnostics - Confusing Diagnosis Process Found Between Alzheimer's and Dementia
Disease Progression - Study Says Alzheimer's Mirrors Child Development
Immunology - Molecule Kills Indirectly by Closing Receptor to Life-Saving Help
Therapy - Drug Saves Brain Cells Attacked by Neurological Injury or Disease
Therapy (Conference News) - Aricept Effective for Long-Term Treatment of AD
Therapy - "Cerebrolysin (CL): A Neurotrophic Agent for the Treatment of Alzheimer's Disease (AD)."
Dance Therapy - "Creative Dance: Potentiality for Enhancing Psychomotor, Cognitive, and Social-Affective Functioning in Seniors and Children."
Environmental Stimulation - "The Relationship of Sound Levels on Special Care Units to Behavior Patterns of Elderly Residents with Dementia."
Acute Care Services - "Use of Physician and Acute Care Services by Persons With and Without Alzheimer's Disease: A Population-Based Comparison."
Biotechnology (apoE2 Production) - "Functional Characterization of Apolipoprotein E Isoforms Overexpressed in Escherichia coli."
Disease Associations - "Serum Zinc, Copper, Insulin, and Lipids in Alzheimer's Disease epsilon 4 Apolipoprotein E Allele Carriers."
Neurodegeneration - "Evidence for Caspase-Mediated Cleavage of AMPA Receptor Subunits in Neuronal Apoptosis and Alzheimer's Disease."
Pathology - "Peripheral Markers of Oxidative Stress in Probable Alzheimer Patients."
Therapy - "A Double-Blind, Placebo-Controlled Trial of Diclofenac Misoprostol in Alzheimer's Disease."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.